The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice
- 1 October 2021
- journal article
- research article
- Published by Elsevier BV in Toxicology
- Vol. 463, 152971
- https://doi.org/10.1016/j.tox.2021.152971
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireProceedings of the National Academy of Sciences of the United States of America, 2012
- HLA‐B*1502 Strongly Predicts Carbamazepine‐Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic PainPain Practice, 2011
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009
- Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug HypersensitivityImmunity, 2008
- HLA-B*5701 Screening for Hypersensitivity to AbacavirThe New England Journal of Medicine, 2008
- Immune responses to abacavir in antigen-presenting cells from hypersensitive patientsAIDS, 2007
- Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactionsPharmacogenetics and Genomics, 2006
- T-cell anergyCurrent Opinion in Immunology, 2004
- CD28-mediated co-stimulation: a quantitative support for TCR signallingNature Reviews Immunology, 2003
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001